Sign in
CompletedPhase 4

Immune Response to High-Dose vs. Standard Dose Influenza Vaccine

Key facts

Who runs it
Health Sciences North Research Institute
Where
Farmington, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Status
Completed
Phase
Phase 4
People taking part
393 people enrolled
Started
1 Feb 2014
Ended
21 Sept 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Flu Vaccine
Record updated
5 October 2026

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Written informed consent provided by the participant
  • Age 20-40 years old with no underlying chronic diseases or age ≥65 years old
  • Willing to receive influenza vaccination
  • Older cohort has received their influenza vaccine for the previous influenza season; -

Who cannot take part

  • Have not received influenza vaccination in the past or cannot be vaccinated due to previous severe reaction to influenza vaccine, egg, latex, or thimerosol allergies, or refusal of vaccination
  • Participant has received a community available influenza vaccine for the approaching influenza season
  • Immunosuppressive disorders or medications (including oral prednisone in doses >10 mg daily)
  • Females who are pregnant at Visit 1 (a pregnancy test will be administered for all females of child-bearing potential); -

Where in United States

Also in 1 other country, 1 site

  • Center on Aging, UConn HealthFarmington, United States

About the trial

What the trial wants to find out

This 5-year proposal is a randomized study of split-virus influenza vaccine (SVV) in a high-dose (HD) vs. standard-dose (SD) formulation in each of five influenza seasons to define the key determinants of vaccine-mediated protection against influenza and how these immunologic mediators may be enhanced by vaccination with a newly approved high-dose influenza vaccine in older people

The 2 groups in the trial

  • Flu Vaccine SDExisting treatment, for comparison

    Fluzone Standard Dose Influenza Vaccine

    Treatment: Flu Vaccine

  • Flu Vaccine HDExisting treatment, for comparison

    Fluzone High Dose Influenza Vaccine

    Treatment: Flu Vaccine

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
5 October 2026